Among the upregulated genes, S100A8 and S100A9 were associated with poor prognosis in patients with ESCC and enhanced the migration and invasion abilities of ESCC cells via the Akt and p38 MAPK signaling pathways [20]. This evidence concerns the gene S100A8 and esophageal squamous cell carcinoma.